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Abstract 
Lactobacillus paracasei DG is a bacterial strain with recognized probiotic properties and is used in 
commercial probiotic products. However, the mechanisms underlying its probiotic properties are 
mainly unknown. In this study, we tested the hypothesis that the capability of strain DG to interact with 
the host is, at least partly, associated with its ability to synthesize a surface-associated 
exopolysaccharide (EPS). Comparative genomics revealed the presence of putative EPS gene 
clusters in DG genome; accordingly, EPS was isolated from the surface of the bacterium. A sample of 
the pure EPS from strain DG (DG-EPS), upon NMR and chemical analyses, was shown to be a novel 
branched hetero-EPS with a repeat unit composed of L-rhamnose, D-galactose, and N-acetyl-D-
galactosamine in a ratio of 4:1:1. Subsequently, we demonstrated that the DG-EPS displays 
immunostimulating properties by enhancing the gene expression of the pro-inflammatory cytokines 
TNF-α and IL-6, and, particularly, the chemokines IL-8 and CCL20 in the THP-1 human monocytic cell 
line. In contrast, the expression of the cyclooxygenase enzyme COX-2 was not affected. In 
conclusion, the DG-EPS is a bacterial macromolecule with the potential ability to boost the immune 
system as either a secreted molecule released from the bacterium or as a capsular envelope on the 
bacterial cell wall. This study provides additional information about the mechanisms supporting the 
cross-talk between L. paracasei DG and the host. 
Importance 
The consumption of food products and supplements named probiotics, i.e. containing live microbial 
cells, to potentially prevent or treat specific diseases, is constantly gaining popularity. The lack of 
knowledge on the precise mechanisms supporting their potential health-promoting properties, 
however, greatly limits a more appropriate use of each single probiotic strain. In this context, we 
studied a well-known probiotic, Lactobacillus paracasei DG, in order to identify the constitutive 
molecules that can explain the documented health-promoting properties of this bacterium. We found a 
novel polysaccharide molecule, named DG-EPS, that is secreted by and covers the bacterium. We 
demonstrated that this molecule, which has a chemical structure never identified before, has 
immunostimulatory properties and, therefore, may contribute to the ability of the probiotic L. paracasei 
DG to interact with the immune system.   
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Introduction 
Strains of Lactobacillus paracasei are Gram-positive, non-spore-forming bacteria that are common 
inhabitants of the human intestinal tract. Specific strains of L. paracasei are found naturally in a 
number of fermented food products, and they have traditionally been used in the production of 
fermented milks and cheeses. More recently, specific strains of L. paracasei have been used in 
probiotic dietary supplements, including the strain L. paracasei DG (commercially known as L. casei 
DG, Enterolactis®).  A range of health-promoting properties have been assigned to L. paracasei DG 
including the improvement of ulcerative colitis (1) and a reduction in the side effects associated with 
therapies for eradication of Helicobacter pylori (2), and treatment of small intestinal bacterial 
overgrowth (3). It has also been shown that L. paracasei DG is able to modulate fecal Clostridiales 
bacteria and butyrate levels in healthy adults (4). Despite the significant clinical evidence for the 
health benefits associated with the consumption of L. paracasei DG, the molecular mechanisms 
underlying these health effects are still unknown. 
A number of mechanisms have been proposed for the probiotic effect. One of the most studied 
mechanisms relates to the ability of probiotic bacteria to antagonize pathogenic organisms by either 
excretion of antimicrobial agents (5) or the displacement of pathogenic organisms through the 
competitive occupancy of adhesion sites (6). In addition, there are a number of reports suggesting 
that health benefits result from stimulation of the immune system by components presented at the 
surface of probiotic strains (7, 8). Both in vivo and in vitro experiments have demonstrated that the 
polysaccharides present at the surface of the bacteria, referred to as either capsule or as 
exopolysaccharides (EPSs), can play a role in both the displacement of pathogenic organisms and 
the stimulation of the immune system (9, 10). 
In an attempt to understand the molecular mechanisms underlying the probiotic activity of L. 
paracasei DG, we undertook a study to identify EPS molecules in L. paracasei DG. We isolated, 
purified, and characterized a novel EPS molecule (that we named DG-EPS), and studied its ability to 
mediate DG’s probiotic properties by monitoring adhesion on a Caco-2 cell layer and the 
immunostimulatory activity on Caco-2 enterocyte-like and THP-1 macrophage-like cell models. 
Materials and Methods 
Unless otherwise stated, all reagents were purchased from Sigma-Aldrich Company Ltd. (Poole, 
Dorset, UK) and were used as supplied. 
Identification of the putative EPS gene cluster 
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The draft genome sequence of L. paracasei DG was obtained through Ion Torrent PGM (Life 
Technologies, Germany) as previously described (11). The raw sequence data were assembled using 
MIRA v.3.9 (http://www.chevreux.org/projects_mira.html), applying default parameters recommended 
for Ion Torrent data processing. Initial automated annotation of the genome was performed using RAST, 
combined with BLASTX. Results of the gene-ﬁnder program were combined manually with data from 
BLASTP analysis against a non-redundant protein database provided by the National Center for 
Biotechnology Information (NCBI). The DG draft genome sequence was compared with other L. 
paracasei genome sequences by means of BLAST Ring Image Generator (BRIG; (12)). The functional 
annotation of the EPS-b region was carried out by combining the results of BLASTN, BLASTP and the 
“CD-search” of the Conserved Domain Database (CDD) available at the NCBI website 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). 
EPS isolation and purification 
Lactobacillus paracasei strain DG (deposited at the National Collection of Microorganisms Cultures of 
the Pasteur Institute under the code CNCM I-1572) was grown at 37°C in de Man-Rogosa-Sharpe 
(MRS) broth (Difco Laboratories Inc., Detroit, MI) for 24 h. This culture was used to inoculate the 
chemically defined medium (CDM, Table 1).  The multistep extraction and puriﬁcation of EPS was 
performed from about 1 l of CDM supplemented with 2% glucose. After growth at 37°C for 48 h, cells 
were collected by centrifugation at 12,000 × g for 15 min at 4°C (Avant J-26 XPI, Beckman Coulter Ltd, 
High Wycombe, UK) and separated from the exhausted medium. The two fractions were then treated 
separately. The exhausted medium was added with an equal volume of absolute ethanol and stored at 
4°C for 48 h. After storage, it was centrifuged at 25,000 × g for 35 min at 4°C. The obtained pellet 
(fraction S1) was dissolved in deionized water (about 20-50 ml), whereas the supernatant was added 
to a second volume of ethanol and stored again at 4°C for 48 h. Subsequently, the centrifugation step 
was repeated, and the pellet (fraction S2) was dissolved in deionized water as above. Concerning cell 
fractions, the pellet was washed with phosphate-buffered saline (PBS) to remove polysaccharide 
impurities and then treated with 1 M sodium hydroxide and stirred overnight at 4°C. Afterwards, it was 
centrifuged again at 12,000 × g 4°C for 15 min in order to remove sodium hydroxide. Crude EPS was 
precipitated by the addition of an equal volume of chilled absolute ethanol; this was stored 48 h at 4°C 
and then centrifuged at 25,000 × g 4°C for 35 min. The recovered pellet (fraction C1) was re-dissolved 
in deionized water (about 20 ml). The resulting supernatant was then added to a second volume of 
absolute ethanol and again incubated 48 h at 4°C. Another centrifugation, as described above, a second 
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precipitated fraction (C2) was recovered, which was dissolved in deionized water. Small neutral sugars 
and proteins were then removed by dialysis (with 100 kDa cut-off cellulose acetate membranes) of the 
extracted fractions for 72 h at 4°C, against three changes of deionized water per day. After three days, 
the contents of the dialysis membrane were collected and lyophilized in a freeze-dryer (Northern 
Scientific, York, UK). The dry mass of EPS was then determined. The presence of contaminating 
bacterial DNA in the EPS preparations was tested through real-time quantitative PCR (qPCR) with two 
primer pairs: universal primers targeting 16S rRNA gene (EUB), and DG strain specific primers targeting 
welF gene (13). This analysis revealed the presence of 10-63 ng ml-1 in the 1 mg ml-1 stock solutions of 
EPS, corresponding to an overall maximum concentration of 0.6 ng ml-1 of DNA incubated with THP-1 
cells when the highest concentration of EPS (10 µg ml-1) was used in immunological experiments.Table 
1. Chemically defined medium (CDM) used to cultivate L. paracasei DG for the extraction of 
the exopolysaccharide (EPS). 
Component  Concentration (g l-1) 
Sol. 1   
(NH4)2SO4 2 
MgSO4 × 7 H2O 0.15 
MnSO4 × 4 H2O 0.02 
Sol. 2   
Adenine 0.005 
Pyridoxal 0.002 
Nicotinic acid 0.001 
Ca2+-D-pantothenate 0.001 
Riboflavin 0.001 
Thiamine 0.001 
Vitamin B12 0.000001 
Biotin 0.00001 
p-aminobenzoic acid 0.000005 
Folic acid 0.00001 
Sol. 4 *  
Guanine 0.005 
Xanthine 0.005 
Uracil 0.005 
Sol. 5   
K2HPO4 4.56 
Sol. 6   
Sodium acetate 0.05 
Sodium citrate 0.02 
KH2PO4 0.01 
NaCl 0.002 
CaCl2 0.002 
Sol. 7   
Tween 80 1 
Tween 20 1 
Glycerol 1 
Glucose  20 
Casaminoacids  10 
* Dissolved in 1 M NaOH. An equal volume of 1 M HCl 
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Determination of monomer composition and linkage analysis 
To determine the monomer composition of the polysaccharide, the EPS (3 mg) was hydrolyzed by 
treatment with 2 M trifluoroacetic acid (TFA, 120°C for 2 h); the released monosaccharides were 
subsequently derivatized to form alditol acetates which were analyzed by gas chromatography–mass 
spectrometry (GC-MS). To derivatize the monomers, the mix resuspended in 1 ml Milli-Q water was 
added with 10 mg NaBH4 and incubated at 40°C for 2 h. After evaporation of the solution, 1 ml glacial 
acetic acid was added to the residue, and again evaporated to dryness. Subsequently, 3 ml methanol 
were added and then evaporated in order to remove the borate complex and to give the methylated 
sugar alditols. They were then added with 2 ml pyridine and 2 ml acetic anhydride; acetylation reaction 
ran at 100°C for 2 h. At the end of the reaction the solution was evaporated and the acetylated 
monomers resuspended in water. Extraction with chloroform was performed to collect the organic 
phase, containing the alditol acetate sugars. Any trace of water was removed by adding anhydrous 
sodium sulphate and storing the sample 30 min at 4°C. Sodium sulphate was removed by filtration on 
filter paper and chloroform by evaporation. The resulting residue was resuspended in acetone. The GC-
MS analysis was performed on an Agilent 7890A GC system (Santa Clara, CA, USA) coupled to an 
Agilent 5675c quadrupole MS. The samples were eluted from a HP-5 column (30 m x 0.25 mm id, 0.25 
µm film) using helium as carrier (9 psi, flow rate 1 ml min-1) and using a temperature program (start 
temperature 150°C, hold time 4 min, and a final column temperature of 250°C reached via a rising 
gradient of 4°C min-1). The ratios of the different sugars were determined by examination of the relative 
responses of the different alditol acetates with reference to the relative responses determined for a 
standard mixture of alditol acetates. As previously reported (14), the integral area for amino sugars was 
low, and this is a result of their having undergone thermal decomposition during analysis. The final 
monomer ratio, for the amino sugar, was taken from integration of the nuclear magnetic resonance 
(NMR) peak integrals for the respective anomeric and H2 protons. The absolute configurations of 
monosaccharides were determined by conversion to their 2-butyl glycosides using the procedure 
described by Gerwig et al. (15). To determine the linkage pattern of the EPS, the sample was 
permethylated using the procedures described by Ciucanu and Kerek (16). The permethylated 
polysaccharide was then hydrolyzed (2 M TFA, 120°C for 2 h) and the methylated monosaccharides 
converted to methylated alditol acetates. The identity of the methylated alditol acetates was determined 
by analysis of their individual mass spectrum fragmentation patterns generated during GC-MS analysis. 
The GC-MS analyses were performed on the same instrumentation as the monomer analysis but using 
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the following temperature program: start temperature 155°C, hold time 1 min, and a final column 
temperature of 195°C reached via a rising gradient of 0.75°C min1. 
NMR analysis of the EPS from L. paracasei 
Nuclear magnetic resonance (NMR) spectra were recorded for EPS samples that were dissolved (10-
20 mg ml-1) directly in D2O (Goss Scientific Instruments Ltd., Essex, UK). NMR spectra were recorded 
at a probe temperature of 70°C. NMR spectra were recorded on a Bruker Avance 500.13 MHz 1H 
(125.75 MHz 13C) spectrometer (Bruker-Biospin, Coventry, UK) operating with Z-field gradients where 
appropriate and using Bruker’s pulse programs. Chemical shifts are expressed in ppm relative to 
internal acetone (δ 2.225 for 1H and δ 31.55 for 13C). Spectra recorded included: a 2D gradient-selected 
double quantum filtered correlation spectrum (gs-DQF-COSY) recorded in magnitude mode at 70°C; 
total correlation spectroscopy (TOCSY) experiments recorded with variable mixing times (60, 90, 120 
ms); 1H-13C heteronuclear single quantum coherence (HSQC) spectra (decoupled and coupled); a 
heteronuclear multiple bond correlation (HMBC) spectrum; and finally, a rotating frame nuclear 
Overhauser effect spectrum (ROESY). The 2D spectra were recorded with 256 experiments of 1024 
data points. The ROESY spectrum was recorded using a Bruker pulse sequence and 256 experiments 
of 1024 data points using a mixing time of 200 ms. For the majority of spectra, time-domain data were 
multiplied by phase-shifted (squared-) sine-bell functions. After applying zero-filling and Fourier 
transformation, data sets of 1024-1024 points were obtained. 
Bacterial adhesion to Caco-2 cell line 
The adhesion of L. paracasei strains to Caco-2 (ATCC HTB-37) cell layer was assessed as previously 
described (13). In brief, for adhesion experiments, fully differentiated Caco-2 cells were used (i.e., 15 
days after conﬂuence). 100 µg ml-1 EPS was incubated with a monolayer of Caco-2 cells for 1 h at 37°C. 
Finally, monolayers were examined microscopically (magniﬁcation, 400×) under oil immersion after 
Giemsa staining (17). All experiments were performed in duplicate. 
Nuclear factor κB (NF-κB) activation by exopolysaccharides 
The activation of nuclear factor κB (NF-κB) was studied by means of a recombinant Caco-2 cell line 
stably transfected with vector pNiFty2-Luc (InvivoGen, Labogen, Rho, Italy) as described in detail 
elsewhere (18, 19). In brief, recombinant Caco-2 monolayers (approximately 3×105 cells/well), 
cultivated in the presence of 50 µg ml-1 zeocin, were washed with 0.1 M Tris-HCl buffer (pH 8.0) and 
then suspended in fresh Dulbecco's Modified Eagle Medium (DMEM) containing 100 mM HEPES (pH 
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7.4) and with 0.1 ml of L. paracasei DG-EPS, corresponding to a final concentration of 100 µg ml-1. The 
stimulation was conducted by adding 10 ng ml-1 of interleukin (IL)-1β. After incubation at 37°C for 4 h, 
the samples were treated, and the bioluminescence was measured as described by Stuknyte et al. (19). 
Two independent experiments were conducted in triplicate for each condition. 
Activation of THP-1 human macrophage cell line: cell culture, growth conditions, and 
stimulation protocol 
The monocytic THP-1 cell line was purchased from the American Type Culture Collection (Manassas, 
VA, USA). THP-1 cells were originally cultured from the peripheral blood of 1-year child with acute 
monocytic leukemia (20). They are non-adherent cells, which can be differentiated into macrophage-
like cells through a protein kinase C-mediated reactive oxygen species (ROS)-dependent signaling 
pathway (21) by treatment with phorbol myristate acetate (PMA). The normal growth medium for THP-
1 cells consisted of RPMI 1640 medium (Lonza, Basel, Switzerland) supplemented with 10% (v/v) fetal 
bovine serum (FBS) (Gibco-BRL, Life Technologies, Milan. Italy), 2 mM L-glutamine, 100 units ml-1 
penicillin and 100 μg ml-1 streptomycin (Sigma-Aldrich). Cells were seeded at a density of 5×105 
cells/well in 24-well plates and incubated at 37°C in a humidified atmosphere of 95% air and 5% CO2. 
Differentiation was induced by the addition of PMA (Sigma-Aldrich) into the cellular medium at a final 
concentration of 100 nM and was allowed to proceed for 24 h. Afterwards, cells were washed once with 
sterile PBS buffer to remove all non-adherent cells, and fresh complete medium was added. Bacteria 
were used at the multiplicity of infection (MOI) of 50, EPS at final concentrations of 0.1, 1, and 10 μg 
ml-1; lipopolysaccharide (LPS) from Salmonella enterica (Sigma-Aldrich) was used at a final 
concentration of 1 μg ml-1. An untreated sample, i.e., only RPMI 1640 medium with 10% (v/v) FBS, was 
used as control. 
Preparation of RNA and Real-time Quantitative PCR (qRT-PCR) 
After incubating THP-1 cells at 37°C for 4 h, the supernatant was carefully removed from each well, 
and the total cellular RNA was isolated from the adhered cells with the Total RNA Blood and Cultured 
Cells Kit (GeneAid, New Taipei City, Taiwan). Afterwards, traces of DNA were removed by treatment 
with DNAse enzyme (Sigma-Aldrich), following the manufacturer’s instructions. RNA concentration and 
purity was determined with a Take3 Multivolume Plate Reader (Biotek, Luzern, Switzerland), and 
reverse transcription to cDNA was performed with the iScript Select cDNA Synthesis Kit (Bio-Rad 
Laboratories, Hercules, CA), using the following thermal cycle: 5 min at 25°C, 30 min at 42°C, and 5 
min at 85°C. Real-time Quantitative PCR (qRT-PCR) was carried out in order to measure the mRNA 
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expression levels of cytokines by means of the SYBR Green technology using the SsoFast EvaGreen 
Supermix (Bio-Rad) on a Bio-Rad CFX96 system according to the manufacturer's instructions. The 
primers were as follows (5’3’): GAPDH forward, 5’-GGGAAGGTGAAGGTCGGAGT-3’; GAPDH 
reverse, 5’-TCAGCCTTGACGGTGCCATG-3’; IL-6 forward, 5’-CGGTACATCCTCGACGGCAT; IL-6 
reverse, 5’-TCACCAGGCAAGTCTCCTCAT-3’; IL-8 forward, 5’- TGTGGTATCCAAGAATCAGTGAA-
3’; IL-8 reverse, 5’-TATGTTCTGGATATTTCATGGTACA-3’; CCL20 forward, 5’-
CTGCTTGATGTCAGTGCTG; CCL20 reverse, 5’-CACCCAAGTCTGTTTTGG-3’; TNF-α forward, 5’-
TCAGCTCCACGCCATT-3’; TNF-α reverse, 5’-CCCAGGCAGTCAGATCAT-3’; COX-2 forward, 5’-
CCCTTGGGTGTCAAAGGTAA; COX-2 reverse, 5’-TGAAAAGGCGCAGTTTACG-3’. All primers were 
designed previously, and their specificity was assessed with melting curves during amplification and by 
1% agarose gels (22). Quantitative PCR was carried out according to the following cycle: initial hold at 
95°C for 30 s and then 39 cycles at 95°C for 2 s and 60°C (for TNF-α and cyclooxygenase COX-2) or 
58.2°C (for IL-6, IL-8 and CCL20) for 5 s. Gene expression was normalized to the reference 
glyceraldehyde-3-phosphate dehydrogenase (gapdh) gene. The amount of template cDNA used for 
each sample was 15 ng. All results regarding cytokine mRNA expression levels are reported as the fold 
of induction (FOI) relative to the control (namely unstimulated THP-1), to which we attributed a FOI of 
1. Statistically significant differences have been determined through unpaired Student’s t test with a 
two-tailed distribution. 
Results  
Identification of putative genetic clusters for exopolysaccharide biosynthesis 
In light of the potential importance of EPS molecules in the cross-talk between probiotic bacteria and 
host (9, 10, 23), we performed in silico analyses to identify putative EPS operons in the draft genome 
of the probiotic strain L. paracasei DG. Specifically, comparative analysis with other genomes of the 
same species led to the identification in the genome of strain DG of two different regions encoding 
open reading frames (ORFs) putatively involved in the biosynthesis of EPS molecules (regions EPS-a 
and EPS-b in Fig. 1A). Notably, whereas EPS-a region is common to all L. paracasei genomes 
investigated, EPS-b is a 13 kb region coding for several putative glycosyltransferases that includes a 
region of about 7 kb in the center of the cluster which did not find any match with other sequences in 
GenBank according to BLASTN search (Fig. 1B). The %GC of the 7 kb region is much lower (36%) 
than the average GC content of DG’s whole genome (approximately 46%) supporting the idea of the 
acquisition of these genes by horizontal gene transfer from a phylogenetically unrelated host.  
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The identification of putative EPS operons in the genome of L. paracasei DG, along with the 
formation of a much weaker pellet after centrifugation compared to other L. paracasei strains (24) 
were considered as an indication of the probable ability of strain DG to produce EPS molecules. 
Consequently, we undertook experiments aimed at the extraction and purification of the EPS fraction 
from DG’s broth cultures. 
Fig 1A 
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Fig. 1. Comparative genomic analysis of Lactobacillus paracasei DG with other 
complete genome sequences of L. paracasei strains. (A) Circular genome atlas of L. 
paracasei (reference genome) and six other publicly available L. paracasei genomes; 
highlighted in the atlas are the two putative exopolysaccharide (EPS) regions of strain DG. 
(B) In silico predicted functional organization of the EPS-b region of L. paracasei DG; the 
figure shows the BLASTN search results for the region EPS-b and has been obtained by 
adding a picture of the putative EPS gene cluster over the graphic representation of the 
BLASTN output. In white are indicated open reading frames (ORFs) outside the putative 
EPS operon; in black are ORFs that do not share significant homology with other sequences 
in GenBank. D.R., direct repeat sequences. 
 
Production and isolation of the EPS from L. paracasei DG 
A culture of L. paracasei DG was grown in a CDM. Although growth was slower than that observed in 
more conventional media such as MRS broth, CDM was chosen as it does not contain contaminating 
polysaccharides which interfere with the characterization of bacterial polysaccharides by NMR (25). In 
order to isolate a sample of polysaccharide suitable for characterization, it was necessary to grow L. 
paracasei DG for three days, at which point the cell biomass was separated from the fermentation 
liquors by centrifugation. High purity EPS was isolated from the supernatant by fractional precipitation 
of material. Adding one volume of ethanol released small amounts of an EPS material contaminated 
with proteins (typically 20-25 mg from a 500 ml batch fermentation). The addition of a second volume 
of ethanol also precipitated a relatively small amount of EPS (20-25 mg) but with much greater purity 
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and of a purity that was suitable for characterization by NMR. As the yields of EPS were low, and in 
order to determine if additional material was being retained with the biomass, various different 
methods were attempted in order to recover capsular material bound to the cells. Stirring a 
suspension of the cells overnight in an aqueous solution of sodium hydroxide (1 M) and then 
precipitating crude polysaccharide by adding two volumes of ethanol yielded a significant amount of 
material which included both polysaccharide and protein. The same approach was adopted for the 
isolation of extracellular polysaccharide molecules from strain L. paracasei LPC-S01, whose genome 
was reported to harbor two distinct putative EPS operons (13), one of which was identical to EPS-a of 
strain DG. However, we failed to obtain significant amounts of EPS from LPC-S01. 
The purity of the EPSs released into the supernatant was established by examination of a 1H-
NMR spectrum of the sample (Fig. 2A). The low-field region of the spectrum contained six anomeric 
signals. Within the error of the experiments, the peak area integrals for each of the anomeric signals 
were the same, implying that a single EPS having a repeating unit containing six monosaccharides 
had been isolated. In addition to the anomeric signals, a single resonance with an integral height of 
three was visible at a chemical shift of 2.05 ppm which is indicative of the presence of an N-
acetylhexosamine and a further two sets of overlapping doublets, each integrating to six protons, 
were present at 1.25 &1.32 ppm; these signals indicated that the repeat unit contained four 6-
deoxyhexoses. 
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Fig. 2. NMR analysis of the exopolysaccharide (EPS) isolated from Lactobacillus paracasei DG. (A) 
Selected regions of the1H-NMR of the DG-EPS recorded at 70°C in D2O and using acetone as an 
internal standard, anomeric (H-1) resonances are labelled A-F in order of decreasing chemical shift. 
(B) Selected regions of overlaid COSY (black contours) and TOCSY (grey contours) spectra for the 
DG-EPS recorded at 70°C; symbols A-F identify individual sugars and numbers (1-6) identify the C/H 
ring position. ((C) Selected regions of the HSQC spectrum of DG-EPS; the location of the individual 
ring and H6-protons and carbons are identified on the top frame, and the location of the anomeric 
protons and carbons are identified on the bottom frame. The spectrum was recorded in D2O at 70°C. 
(D) Anomeric region of a ROESY spectrum recorded for the DG-EPS; inter- and intra-residue NOEs 
from the anomeric hydrogens to ring protons are individually labelled. 
 
 
 
 
Monomer, linkage analysis, and determination of the absolute configuration of the 
monosaccharides in the repeating unit structure 
GC-MS analysis of the alditol acetates generated during monomer analysis of the EPS identified the 
presence of 1,2,3,4,5-penta-O-acetyl-L-rhamnitol, 1,2,3,4,5,6-hexa-O-acetyl-D-galactitol, and 2-
acetamido-1,3,4,5,6-penta-O-acetyl-2-deoxy-D-galactitol in a ratio of 4:1:1. The results of the 
monomer analysis identified the presence of rhamnose, galactose, and N-acetylgalactosamine in the 
repeating unit. 
The methylated alditol acetates generated during linkage analysis included: a 1,5-di-O-acetyl-
2,3,4,6-tetra-O-methylhexitol which confirms that the galactose is present in its pyranose form as a 
terminal sugar; a 1,3,5-tri-O-acetyl-2-(acetylmethylamino)-2-deoxy-4,6-di-O-methylgalacitol, which 
confirms that the N-acetylgalactosamine is present in its pyranose form as a 1,3-linked 
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monosaccharide; two 1,2,5-tri-O-acetyl-3,4-di-O-methyl-6-deoxyhexitols, which indicates that two of 
the rhamnose monomers are 1,2-linked; a 1,3,5-tri-O-acetyl-6-deoxy-2,4-di-O-methylhexitol, which 
indicates that one of the rhamnose monomers is 1,3-linked; and finally a 1,2,3,5-tetra-O-acetyl-6-
deoxy-4-O-methylhexitol suggesting that the final rhamnose is a 1,2,3-linked rhamnose present as a 
bridging point in the repeating unit. 
Conversion of the monomers to mixtures of their epimeric 2-butyl-glycosides confirmed that all the 
rhamnose monomers were of L-absolute configuration whilst both the galactose and N-
acetylgalactosamine were of D-absolute configuration. 
Determination of the sequence of the monomers in the repeat unit using 1D & 2D NMR 
The chemical shifts of each of the protons and carbons in the repeat unit were determined through the 
inspection of a series of 1D & 2D NMR spectra, and these are listed in Table 2. Analysis of the 1H-1H 
COSY spectrum (Fig. 2B, black contours) in combination with the 1H-1H TOCSY spectrum (Fig. 2B, 
grey contours) allowed the scalar coupling within the individual sugars to be tracked from the anomeric 
protons (labelled A to F in order of decreasing chemical shift- see Fig. 2A) from H1 to H6 in the 
rhamnose sugars (A, B, C, and D) and from H1 to H4 in the galactose and N-acetylgalactosamine 
monomers (Fig. 2B). 
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Table 2. The chemical shifts of protons and carbons in the repeat unit of L. paracasei DG 
exopolysaccharide (DG-EPS) determined through the inspection of a series of 1D & 2D NMR 
spectra. 
Position A B C D E F 
H1 
(C1) 
5.30 
(102.6) 
5.21 
(102.2) 
5.15 
(102.4) 
4.87 
(102.5) 
4.72 
(103.5) 
4.53 
(106.0) 
H2 
(C2) 
4.21 
(79.8) 
4.07 
(79.6) 
4.13 
(80.3) 
3.90 
(71.6) 
3.82 
(57.1) 
3.59 
(72.5) 
H3 
(C3) 
4.01 
(78.2) 
3.91 
(72.0) 
3.86 
(71.3) 
3.79 
(79.5) 
3.65 
(83.1) 
3.63 
(76.5) 
H4 
(C4) 
3.67 
(70.4) 
3.49 
(73.6) 
3.35 
(73.7) 
3.55 
(72.9) 
3.54 
(72.6) 
3.93 
(70.1) 
H5 
(C5) 
3.82 
(70.6) 
3.77 
(70.6) 
3.66 
(73.8) 
4.02 
(70.5) 
3.45 
(77.3) 
3.53 
(70.0) 
H6 
(C6) 
1.32 
(18.6) 
1.32 
(18.1) 
1.25 
(18.0) 
1.25 
(17.9) 
3.91/3.75 
(62.4) 
3.75 
(62.3) 
Acetyl 
(CH3CO)    
CH3 δ 2.05 
CH3 δ 23.5 
CO δ 175.6 
  
 
 
A HSQC spectrum was used to correlate ring carbons with their attached protons (Fig. 2C) and the 
distinctive position of C2 and identification of H2 of the N-acetylgalactosamine confirmed, by 
observation of scalar coupling to H1 resonance at 4.72 on the COSY spectrum, that the anomeric 
resonance at 4.72 ppm (E in Fig. 2A) was that of the N-acetylgalactosamine. The remaining anomeric 
resonance at 4.53 ppm must therefore belong to the terminal galactose. 
Through inspection of the carbon chemical shifts of the rhamnose ring carbons, it was 
possible to identify points of linkages by locating those carbons whose chemical shifts had moved 
towards low-field positions (above 78 ppm) compared to the values normally associated with 
unsubstituted ring positions (less than 74 ppm for rhamnose sugars). This identified A as a 2,3-linked 
rhamnose (C2, δ 79.8 ppm; C3, δ 78.2 ppm), B as a 2-linked rhamnose (C2, δ 79.6 ppm), C as a 2-
linked rhamnose (C2, δ 80.3 ppm), and D as a 3-linked rhamnose (C3, δ 79.5 ppm). The results of the 
linkage analysis already identified that the N-acetylgalactosamine (E) is 1,3-linked, and this was 
confirmed by the high chemical shift of C-3 in E (δ 83.1 ppm). Finally, the chemical shifts of the 
carbons in residue F are in agreement with this being a terminal galactose monomer. 
The anomeric configuration of the monosaccharides was determined by measuring the 1JC1-H1 
coupling constants which were visible on a coupled HSQC spectrum (not shown). Residues A to D 
had 1JC1-H1 coupling constants A (177 Hz), B (172Hz), C (175Hz), and D (174 Hz) which are more 
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than 170 Hz, which indicates that the rhamnose residues are alpha-linked, whilst the size of the 1JC1-H1 
coupling constants in E (164 Hz) and F (157 Hz) identifies these two resonances as beta-linked 
monomers. 
Finally, the sequence of the sugars in the repeating unit was established through inspection of 
both a 1H-13C-HMBC spectrum (not shown) and a 1H-1H-ROESY spectrum (Fig. 2D). Inter-residue 
scalar coupling observed on the HMBC spectrum included: coupling between A-H1 & D-C3, indicating 
A is linked to the 3-position of D; coupling between C-H1 & B-C2, indicating C is linked to the 2-
position of B; coupling between D-H1 & E-C3, indicating D is linked to the 3-position of E; coupling 
between F-H1 & A-C2, indicating F is linked to the 2-position of A. On the ROESY spectrum, inter-
residue NOEs were observed: between A-H1 & D-H3, confirming the A(1-3)D linkage; between B-H1 
and A-H3 (strong) and A-H4 (moderate), identifying that B is linked to the 3-position of A; between C-
H1 & B-H2, confirming the C(1-2)B linkage; between D-H1 & E-H3, identifying a D(1-3)E linkage; 
between E-H1 & C-H2, identifying the E(1-2)C linkage; and also between F-H1 & A-H2, confirming 
the F(1-2)A linkage. 
The combined results of the chemical and NMR analysis of the EPS isolated from L. 
paracasei DG indicates that the DG-EPS is a novel heteropolysaccharide having the repeating unit 
structure reported in Fig. 3. 
 
 
In the following set of experiments, we studied the possible involvement of the characterized EPS 
molecule in mediating the cross-talk between L. paracasei DG and the host. 
Experiments on enterocyte-like Caco-2 cell model 
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In order to investigate the potential ability of the DG-EPS to mediate the bacterium’s interaction with 
the host, we first used the Caco-2 cell line, which is considered a valuable in vitro tool for studying the 
mechanisms underlying the interaction between bacterial cells and the human gut (7, 17, 26). 
In a previous publication, L. paracasei DG was shown to be moderately adhesive on Caco-2 cell 
layer (13). In this study, the potential involvement of DG-EPS was assessed by testing also the 
adhesion ability of strain DG after removal of the EPS molecule (“naked” DG cells, nDG, prepared 
through PBS washes and mild sonication) and upon pre-incubation of Caco-2 cells with purified EPS. 
Several studies demonstrated that bacterial EPS molecules may both promote adhesion (27) or, on 
the opposite, reduce adherence by masking cell-wall adhesins (28). Nonetheless, in our experiments, 
purified EPS was unable to affect the adhesion properties of strain DG. In fact, the adhesion of L. 
paracasei DG was not significantly different from that of nDG and was quite modest (about 300 
bacteria per 100 Caco-2 cells), as previously reported (13); in addition, the adhesion ability was 
unaffected by the co-incubation of the bacterial cells with purified EPS (data not shown). 
Afterwards, Caco-2 cells were employed to investigate the e ﬀect of DG-EPS on the activation of 
the transcription factor NF-κB. We recently showed that L. paracasei DG possesses an evident ability 
to reduce NF-κB activation in Caco-2 cells at baseline and upon stimulation with the pro-inflammatory 
cytokine IL-1β (13), as determined through a reporter system obtained by transfecting Caco-2 cells 
with a luciferase reporter vector (6, 7). Here, we used the same immunological model to test the EPS 
macromolecule isolated from strain DG. We found that the purified EPS molecule, differently from the 
whole bacterial cells and their exhausted broth (13), was unable to affect NF-κB activation both at 
baseline and in the presence of the pro-inflammatory stimulus IL-1β (data not shown). Other L. 
paracasei strains under study (namely, strains LPC-S01 and Shirota) displayed the same ability of 
strain DG in reducing NF-κB activation in Caco-2 cells (13), further suggesting that DG-EPS does not 
contribute to this specific immunomodulatory effect. 
DG-EPS molecule triggers the expression of chemokines and cytokines by THP-1 cells 
We exploited the THP-1 macrophage model to test the immunomodulatory properties of L. paracasei 
DG and its isolated EPS. We quantified through qRT-PCR the gene expression of the tumor necrosis 
factor (TNF)-α, the interleukin (IL)-6, the chemokine (C-C motif) ligand 20 (CCL20), the chemokine IL-
8, and the cyclooxygenase (COX)-2. We tested three concentrations of the purified DG-EPS molecule 
(0.1, 1, and 10 µg ml-1). We also performed the same experiments in the presence of 1 µg ml-1 of the 
pro-inflammatory stimulus LPS. We found that the purified DG-EPS can stimulate the expression of all 
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genes under study in a concentration-dependent manner, with the exception of COX-2 (Fig. 4). In 
particular, the chemokines IL-8 and CCL20 were induced approximately 70-fold by 10 µg ml-1 DG-
EPS, whereas the pro-inflammatory cytokines TNF-α and IL-6 26- and 39-fold, respectively. A similar 
stimulatory profile was observed with bacterial cells of strain DG (MOI 50), even if to a lower extent 
(Fig. S1). In addition, when EPS was removed by PBS washes and mild sonication, the bacterial cells 
of strain DG lost their ability to stimulate the gene expression of TNF-α, IL-8 and CCL20; the addition 
of 1 µg ml-1 purified EPS partially reconstituted the stimulatory capacity of the cells (Fig. S1). 
As expected, the stimulation of THP-1 cells with LPS determined a marked overexpression of all 
tested genes, particularly IL-6, IL-8, and CCL20. However, the addition of DG-EPS did not 
significantly affect the LPS-associated inductions of all tested genes (Fig. 4). 
 
Fig. 4. Gene expression analysis by qRT-PCR in human macrophages THP-1 after 4 h 
stimulation with purified DG-EPS molecule (0.1, 1, and 10 µg ml-1), with or without the 
addition of LPS (1 µg ml-1). Expression levels of TNF-α, IL-6, IL-8, CCL20, and COX-2 are 
shown as the fold change of induction (FOI) relative to the control (unstimulated 
macrophages), which was set at a value of 1 (red line). Data are presented as mean of three 
independent experiments ± standard deviation. Asterisks indicate statistically signiﬁcant 
differences compared to unstimulated (samples under the left Y axis) or LPS-stimulated 
(samples under the right Y axis) THP-1 cells: *, P<0.05; **, P<0.01. 
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 Discussion 
The use of probiotic and, in general, food-grade bacteria as modulators of host immune responses 
appears a promising strategy for the prevention and management of the inflammatory conditions at 
the gut mucosa level. To this aim, the identification of microbial cell components mediating the 
interaction with host cells is of pivotal importance. The enormous biodiversity of the microbial world 
provides a virtually inexhaustible source of molecular stimuli for the immune system, which has been 
to date only marginally explored. Particularly, bacterial cell wall components and secreted molecules 
are key ligands that can interact with the host receptors and activate various signaling pathways, thus 
triggering the final probiotic effect. Among the most studied probiotics, lactic acid bacteria (LAB) 
possess a cell wall that is typically composed of a thick peptidoglycan layer decorated with proteins, 
teichoic acids, and polysaccharides (29), which can act as microbe-associated molecular patterns 
(MAMPs). EPSs, apart from their technological properties and industrial applications, have been 
found to contribute to several health-promoting features of probiotics, such as antitumor, antiulcer, 
immunomodulatory, antiviral, and cholesterol-lowering activities (30, 31), but their mechanisms of 
action have not been clearly established and are probably diverse and complex.  
Thanks to the genomic analysis on L. paracasei strain DG, we could identify two gene clusters 
putatively coding for EPS biosynthesis. Interestingly, GenBank search revealed that one of these 
regions, EPS-b, is unprecedented. Since we failed to obtain knock-out mutants for EPS-b, the link 
between this gene cluster and the production of the DG-EPS, although probable, is not definitely 
demonstrated. Nonetheless, the identification of EPS gene clusters in DG’s genome inspired us to 
investigate biologically the potential presence of EPS molecules on the outer surface of the 
bacterium. 
After purification of the exopolysaccharidic cell fraction of strain DG, we characterized the EPS 
repeating unit by means of chromatographic methods and NMR spectroscopy, establishing that it 
possesses a novel structure. Effectively, the repeating unit structures of a number of different strains 
of the L. casei group of species (i.e., L. casei, L. paracasei, and L. rhamnosus) have previously been 
published (32-38), and the one reported here is different. Moreover, it is also different to those of the 
published structures of the EPSs characterized for a range of LAB (30, 39). A feature of the repeating 
unit structure of the EPS reported here and those of a number of probiotic bacteria is the presence of 
rhamnose in the polymeric backbone (30); nonetheless, the very high content of rhamnose 
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(accounting for two third of the sugar moieties in molarity) in the DG-EPS is, to the best of our 
knowledge, unique in LAB. 
The ability of EPSs isolated from LAB to trigger immunomodulatory responses has been observed 
in several studies (23, 40-43); nonetheless, the definition of a common immunological outcome for 
LAB’s EPSs is a hard (and potentially impracticable) task, because their broad structural diversity may 
influence the recognition by immune system receptors (40). Therefore, any EPS molecule with a 
different monosaccharide sequence may represent a potential novel MAMP. In this context, we 
undertook an in vitro immunological characterization of DG-EPS. The initial experiments clearly 
demonstrated that the previously reported ability of strain DG to modulate NF-κB activation in Caco-2 
enterocytes (13) is independent from the EPS. 
After this preliminary immunological investigation on epithelial cells, we then performed the 
subsequent experiments with macrophages, which are cells more properly belonging to the immune 
system. Macrophages, just like monocytes and dendritic cells, are antigen-presenting cells (APCs) 
responsible for the detection of microorganisms and involved in their clearance through phagocytosis 
and production of pro-inflammatory cytokines. Specifically, in our study, we used the human leukemia 
monocytic cell line THP-1 that, upon differentiation with PMA, expresses a phenotype with similarities 
to human peripheral blood mononuclear cell (PBMC) monocyte-derived macrophages (44). With this 
model, we found that DG-EPS displays immunostimulating properties by enhancing the gene 
expression of the pro-inflammatory cytokines TNF-α and IL-6 and, particularly, the chemokines IL-8 
and CCL20. On the contrary, the expression level of the cyclooxygenase enzyme COX-2 was not 
affected. TNF-α is a cytokine that enhances the expression of accessory molecules involved in 
macrophages to guide memory cells to better access the site of an infection (45). Similar to TNF-α, IL-
6 is among the first cytokines to be produced by APCs during the innate immune response toward 
bacteria. TNF-α and IL-6 have pleiotropic effects such as induction of the acute phase response and 
activation of macrophages and, also together with IL-8, have a crucial role as chemoattractants for 
neutrophils, immature dendritic cells, natural killer cells, and activated T cells (46). Furthermore, 
CCL20 is a chemokine that attracts immature DCs (47), whose induction has been shown to be 
regulated by TNF-α (48) and found to be also elicited by probiotics such as L. rhamnosus GG (49). 
In accordance with the results of our study, in a previous study, the EPS isolated from L. 
rhamnosus KL37 was shown to display a pro-inflammatory profile by inducing the production of TNF-
α, IL-6, and IL-12 in mouse peritoneal macrophages (40). Similarly, in a different study, the EPS from 
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L. rhamnosus RW-9595M, which is a rhamnose-rich heteropolysaccharide 
(rhamnose:glucose:galactose 4:2:1 in molar ratio) like the DG-EPS, elicited TNF-α, IL-6, and IL-12p40 
production by both the murine RAW 264.7 macrophage-like cell line and the PBMCs (50). The ability 
to stimulate the production of pro-inflammatory cytokines by APCs, therefore, could potentially be a 
common property of the (rhamnose-rich) hetero-exopolysaccharides produced by the lactobacilli of 
the L. casei group. 
Notably, in our experiments, the induction of pro-inflammatory cytokines and chemokines was 
much lower upon stimulation with DG-EPS than LPS, even when DG-EPS was used at 10-times 
higher concentration. In addition, when we used EPS or DG cells in combination with LPS, we did not 
observe any additive effect over the induction levels of cytokines triggered by LPS. Accordingly, it was 
proposed that probiotics can moderately stimulate the synthesis of pro-inflammatory cytokines in the 
absence of an inflammatory response, but may have suppressive or no effects when an inflammatory 
response has been already triggered (51). In this context, probiotics, although inoffensive during 
infection-derived inflammations, act as mild boosters of the innate immunity that may contribute to a 
more efficient and quick immune response against potential infectious agents. 
Several studies failed to assign to the EPSs evident immunostimulatory abilities, and it was 
proposed that the EPSs anchored on the bacterial outer surface are immunologically inert molecules 
that prevent cell-wall associated MAMPs from the direct contact with immune cell receptors (28, 52, 
53). However, in our study, the purified EPS produced by L. paracasei DG displayed an 
immunostimulatory activity, particularly in terms of chemokines expression. Thus, the EPS from L. 
paracasei DG, rather than an inert molecule, can be considered a bacterial product that can boost the 
immune system as either a secreted molecule released from the bacterium or also, plausibly, as a 
capsular envelope on the bacterial cell wall. Our results concerning the immunostimulating abilities of 
DG-EPS derive, however, from a preliminary in vitro study, and further investigations are needed in 
order to decipher the potential role of DG-EPS in the in vivo setting, where the final response depends 
on the concertation of signals coming from diverse epithelial and immune cells in an environmental 
context populated by numerous diverse commensal microbes.  
In conclusion, our study provides additional information about the well characterized probiotic 
strain L. paracasei DG by demonstrating that it produces a unique rhamnose-rich hetero-
exopolysaccharide, named DG-EPS, possessing immunostimulatory properties. DG-EPS may 
represent a new molecule for potential nutraceutical and pharmaceutical applications. 
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Figure S1. Gene expression analysis by qRT-PCR in human macrophages THP-1 after 4 h 
stimulation with strain L. paracasei DG (MOI 50) and strain DG after removal of the 
exopolysaccharide (EPS) (nDG; MOI 50), with or without the addition of purified the EPS 
molecule (1 µg ml-1). Expression levels of TNF-α, IL-6, IL-8, and CCL20 are shown as the fold 
change of induction (FOI) relative to the control (unstimulated macrophages), which was set 
at a value of 1 (red line). Data are presented as mean of two independent experiments 
conducted in duplicate ± standard deviation. Asterisks indicate statistically signiﬁcant 
differences: *, P<0.05; **, P<0.01. Non-significant P values under 0.1 are specified in the 
figure. 
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